Editorial: Advances in Parkinson's Disease Research: Exploring Biomarkers and Therapeutic Strategies for Halting Disease Progression.
作者信息
Bougea Anastasia, Degirmenci Yildiz
机构信息
Department of Neurology Medical School of Athens, National and Kapodistrian University of Athens, Athens, Greece.
Neurology Department, Istanbul Health and Technology University (ISTUN), Zincirlikuyu Medicana Hospital Neurology ClinicParkinson's Disease and Movement Disorders Unit, Istanbul, Türkiye.
出版信息
Front Aging Neurosci. 2025 Jun 27;17:1640566. doi: 10.3389/fnagi.2025.1640566. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Advances in Parkinson's Disease Research: Exploring Biomarkers and Therapeutic Strategies for Halting Disease Progression.社论：帕金森病研究进展：探索用于阻止疾病进展的生物标志物和治疗策略。
Front Aging Neurosci. 2025 Jun 27;17:1640566. doi: 10.3389/fnagi.2025.1640566. eCollection 2025.
2
Knowledge and utilization of compensation strategies for Parkinson's disease in Dutch long-term care facilities: A survey among 130 healthcare professionals.荷兰长期护理机构中帕金森病补偿策略的知识与应用：对130名医护人员的调查
J Parkinsons Dis. 2025 Jun 26:1877718X251354928. doi: 10.1177/1877718X251354928.
3
Tissue Factor and Its Cerebrospinal Fluid Protein Profiles in Parkinson's Disease.组织因子及其在帕金森病中的脑脊液蛋白谱。
J Parkinsons Dis. 2024;14(7):1405-1416. doi: 10.3233/JPD-240115.
4
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
5
Impact of Y chromosome loss on the risk of Parkinson's disease and progression.Y染色体缺失对帕金森病风险及病情进展的影响。
EBioMedicine. 2025 May 29;117:105769. doi: 10.1016/j.ebiom.2025.105769.
6
Brain-derived extracellular vesicles: A promising avenue for Parkinson's disease pathogenesis, diagnosis, and treatment.脑源性细胞外囊泡：帕金森病发病机制、诊断和治疗的一条有前景的途径。
Neural Regen Res. 2025 Apr 29. doi: 10.4103/NRR.NRR-D-24-01262.
7
Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis.帕金森病的性别特异性进展：一项纵向混合模型分析。
J Parkinsons Dis. 2025 Jun;15(4):805-818. doi: 10.1177/1877718X251339201. Epub 2025 May 19.
8
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
9
Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria.提高视网膜电图在帕金森病中的诊断潜力：方案与队列标准综述
J Parkinsons Dis. 2025 Jun;15(4):694-709. doi: 10.1177/1877718X251331863. Epub 2025 Apr 29.
10
Potential Exosome Biomarkers for Parkinson's Disease Diagnosis: A Systematic Review and Meta-Analysis.用于帕金森病诊断的潜在外泌体生物标志物：系统评价和荟萃分析。
Int J Mol Sci. 2024 May 13;25(10):5307. doi: 10.3390/ijms25105307.
本文引用的文献
1
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的体育锻炼：系统评价与网状Meta分析
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
2
The epidemiology of Parkinson's disease.帕金森病的流行病学。
Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8.
3
Challenges in Managing Nonmotor Symptoms of Parkinson's Disease in Low-Resourced Settings with Unavailability of Newer Drugs.在资源匮乏且无法获取新药的环境中管理帕金森病非运动症状面临的挑战
Mov Disord Clin Pract. 2024 Feb;11(2):123-128. doi: 10.1002/mdc3.13957. Epub 2024 Jan 3.
4
Cognitive Impairment in Parkinson's Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches.帕金森病认知障碍：关注新兴药物治疗方法的最新概述。
Medicina (Kaunas). 2023 Oct 1;59(10):1756. doi: 10.3390/medicina59101756.
5
Advances in protein-protein interaction network analysis for Parkinson's disease.帕金森病的蛋白质-蛋白质相互作用网络分析研究进展。
Neurobiol Dis. 2021 Jul;155:105395. doi: 10.1016/j.nbd.2021.105395. Epub 2021 May 19.
6
New markers in Parkinson's disease.帕金森病的新标志物。
Adv Clin Chem. 2020;96:137-178. doi: 10.1016/bs.acc.2019.12.001. Epub 2020 Jan 2.
7
The association between lifestyle factors and Parkinson's disease progression and mortality.生活方式因素与帕金森病进展和死亡率的关系。
Mov Disord. 2019 Jan;34(1):58-66. doi: 10.1002/mds.27577.
8
Nonmotor Parkinson's and Future Directions.非运动型帕金森病及未来发展方向。
Int Rev Neurobiol. 2017;134:1493-1505. doi: 10.1016/bs.irn.2017.05.017. Epub 2017 Jul 4.
9
The terminology of akinesia, bradykinesia and hypokinesia: Past, present and future.运动不能、运动迟缓及运动减退的术语：过去、现在与未来
Parkinsonism Relat Disord. 2017 Apr;37:27-35. doi: 10.1016/j.parkreldis.2017.01.010. Epub 2017 Jan 22.
Zotero 插件